Cardiotoxicity of BRAF/MEK Inhibitors Mimicking Apical Hypertrophic Cardiomyopathy.

Cardio-oncology is a new and fast-evolving collaborative subdiscipline of cardiology whose goal is to increase the quality and length of the lives of oncological patients with precise prophylactic and therapeutical interventions. Novel targeted therapies present a challenge to recognize and treat rare adverse cardiovascular effects, usually without any evidence-based guidance. Therefore, scrupulous descriptions of clinical cases and drafting trials for real-world safety are paramount.

Obesity as a risk factor in atrial fibrillation and heart failure.

Objectives: The aim of this article is to provide an insight into the role of obesity as a risk factor, and as a potential etiologic agent of atrial fibrillation (AF) and heart failure (HF).

Methods: A narrative (non-systematic) review article summarizing currently available data regarding the interaction between obesity, AF and HF.

Results: Obesity is considered a risk factor of AF and chronic HF.

Recurrent Infective Endocarditis of the Mitral Valve after Orthotopic Heart Transplantation.

Introduction: Orthotopic heart transplantation is the gold standard for the treatment of advanced heart failure in the absence of contraindications. Infective endocarditis is a rare complication in patients after heart transplantation. The treatment of endocarditis after heart transplantation is challenging since there is a need for ongoing immunosuppression.

A Fast-Growing Myxoma of the Left Atrium.

Introduction: Myxoma of the left atrium is a less typical cause of mitral obstruction. If this develops, a flash pulmonary oedema can be the first manifestation.

Case Description: We present a case report of a 50-year-old woman who was admitted to our internal department because of dyspnoea.

A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature.

Transarterial chemoembolization (TACE) is a minimally invasive treatment for liver cancer, often employed as a bridging therapy or destination treatment for non-operable cases. This case report discusses an 82-year-old woman with a large hepatocellular carcinoma (HCC) who underwent elective TACE due to the high surgical risk associated with her tumor size. Unexpectedly, the patient experienced liver rupture 20 h post-procedure, leading to acute surgical intervention.